{"gene":"CLCN5","run_date":"2026-04-28T17:28:52","timeline":{"discoveries":[{"year":2005,"finding":"ClC-5 is a Cl⁻/H⁺ antiporter (secondary active transporter), not a classical Cl⁻ channel. It carries protons across the plasma membrane when activated by positive voltages, and can extrude protons against their electrochemical gradient. The pore glutamate E211A mutation abolishes H⁺ transport but not Cl⁻ transport, demonstrating that this residue is critical for proton coupling.","method":"Extracellular pH measurements near cell surface in heterologous expression system; site-directed mutagenesis of pore glutamate (E211A)","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 — in vitro functional assay with mutagenesis, high-citation foundational paper replicated by subsequent studies","pmids":["16034421"],"is_preprint":false},{"year":1995,"finding":"Rat CLC-5 expressed in Xenopus oocytes elicits strongly outwardly rectifying anion currents with conductivity sequence NO₃⁻ > Cl⁻ > Br⁻ > I⁻ >> glutamate⁻, establishing it as a functional ion channel/transporter. Expression is predominantly in kidney.","method":"Heterologous expression in Xenopus oocytes; electrophysiology","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution in oocytes, foundational paper with 238 citations","pmids":["8537381"],"is_preprint":false},{"year":1999,"finding":"ClC-4 and ClC-5 directly mediate plasma membrane currents. Point mutations in ClC-5 alter kinetics, ion selectivity (S168T changes selectivity; E211A changes voltage dependence and ion selectivity), confirming these proteins are the channel-forming subunits.","method":"Heterologous expression in Xenopus oocytes and HEK293 cells; site-directed mutagenesis; two-electrode voltage clamp","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis combined with electrophysiology in two expression systems","pmids":["9873029"],"is_preprint":false},{"year":2009,"finding":"ClC-5 operates with a 2 Cl⁻/1 H⁺ antiport stoichiometry. Nitrate uncouples proton transport. Mutation S168P converts ClC-5 into a coupled NO₃⁻/H⁺ exchanger, identifying serine 168 as a determinant of anion specificity. ClC-5 is allosterically stimulated by intracellular protons with apparent pK ~7.2.","method":"Novel extracellular proton imaging method in Xenopus oocytes; site-directed mutagenesis at position 168","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 — quantitative flux measurement plus mutagenesis defining stoichiometry and mechanism","pmids":["19131966"],"is_preprint":false},{"year":2006,"finding":"The cytoplasmic CBS domain of ClC-5 binds ATP and ADP at a specific nucleotide-binding site with high-micromolar affinity. Point mutations that interfere with nucleotide binding alter the transport behavior of ClC-5 expressed in Xenopus oocytes, demonstrating that CBS-domain nucleotide binding regulates transporter activity.","method":"X-ray crystallography of CBS domain with ATP/ADP; equilibrium dialysis; electrophysiology of CBS-domain mutants in Xenopus oocytes","journal":"Nature structural & molecular biology","confidence":"High","confidence_rationale":"Tier 1 — crystal structure combined with binding assay and functional electrophysiology in same study","pmids":["17195847"],"is_preprint":false},{"year":1999,"finding":"CLC-5 subcellular distribution in human kidney co-fractionates best with Rab4, a marker of recycling early endosomes, and co-localizes with albumin-containing endocytic vesicles of the receptor-mediated endocytic pathway in proximal tubular cells.","method":"Subcellular fractionation of human kidney; immunoblotting with Rab4 marker; confocal microscopy in opossum kidney cells","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 — direct fractionation and confocal co-localization, foundational localization paper with 239 citations","pmids":["9931332"],"is_preprint":false},{"year":2000,"finding":"CLC-5 knockout mice develop low molecular weight proteinuria, aminoaciduria, glycosuria, hypercalciuria, and severely impaired proximal tubular endocytosis of horseradish peroxidase, demonstrating that CLC-5 is required for endosomal uptake of low molecular weight proteins in vivo.","method":"Targeted gene disruption in mice (knockout); horseradish peroxidase endocytosis assay; urinary protein and amino acid analysis","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 — clean KO with specific endocytic and biochemical phenotypic readouts, 247 citations","pmids":["11115837"],"is_preprint":false},{"year":2003,"finding":"Loss of ClC-5 in knockout mice impairs endocytosis by causing a trafficking defect of the multiligand receptors megalin and cubilin in proximal tubule cells; megalin and cubilin are selectively lost from the brush border while total kidney content is reduced, despite preserved mRNA levels and normal Rab5a/Rab7 content.","method":"ClC-5 KO mouse; 125I-β2-microglobulin uptake assay; Percoll gradient fractionation; quantitative ultrastructural immunogold labeling; immunohistochemistry","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods in KO mice, 254 citations","pmids":["12815097"],"is_preprint":false},{"year":2002,"finding":"Endosomes from ClC-5 knockout mice acidify at a significantly lower rate than wild-type endosomes, consistent with ClC-5 providing an electrical shunt for the H⁺-ATPase. This endosomal acidification defect leads to impaired endocytosis. Additionally, defective PTH endocytosis raises luminal PTH, stimulating apical PTH receptors and causing phosphaturia and secondary up-regulation of proximal tubular α-hydroxylase.","method":"Endosomal acidification assay in KO vs. wild-type mice; PTH receptor stimulation studies; vitamin D metabolism measurements","journal":"Pflugers Archiv : European journal of physiology","confidence":"High","confidence_rationale":"Tier 2 — functional acidification assay in KO model plus pathway epistasis, 159 citations","pmids":["12548389"],"is_preprint":false},{"year":2003,"finding":"The C-terminal tail of ClC-5 interacts with cofilin, an actin depolymerizing protein. Phosphorylation of cofilin by LIM kinase 1 stabilizes the actin cytoskeleton and strongly inhibits albumin uptake in proximal tubule cells, linking ClC-5's C-terminus to actin dynamics and receptor-mediated endocytosis.","method":"Yeast two-hybrid screen; GST-fusion pulldown; confocal co-localization; LIM kinase 1 overexpression with albumin endocytosis assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — yeast two-hybrid confirmed by pulldown and functional endocytosis assay in two cell lines","pmids":["12904289"],"is_preprint":false},{"year":2009,"finding":"CLC-5 interacts with kinesin family member KIF3B (a microtubule motor) via the COOH-terminus of CLC-5 and the coiled-coil/globular domains of KIF3B. KIF3B overexpression increases CLC-5 surface expression and endocytosis; KIF3B siRNA knockdown has reciprocal effects. CLC-5-containing vesicles transport along KIF3B microtubules.","method":"Yeast two-hybrid; GST pulldown; co-immunoprecipitation (including endogenous); confocal live-cell imaging; siRNA knockdown; albumin/transferrin endocytosis assay","journal":"American journal of physiology. Renal physiology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods including endogenous co-IP and live imaging with functional consequence","pmids":["19940036"],"is_preprint":false},{"year":2003,"finding":"Naturally occurring ClC-5 mutations that truncate the second CBS domain result in failure of ClC-5 to traffic to acidic endosomes; instead, the protein is retained in perinuclear compartments co-localizing with the Golgi complex, identifying CBS domain 2 as required for normal endosomal trafficking.","method":"Subcellular localization of CBS domain mutants by confocal microscopy with organelle markers in transfected cells","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 3 — single-lab localization study using naturally occurring mutations without functional rescue","pmids":["14521953"],"is_preprint":false},{"year":2003,"finding":"ClC-5 mutations in Dent's disease patients cause altered polarity of H⁺-ATPase in proximal tubule cells (basolateral instead of apical distribution) and loss of apical H⁺-ATPase in α-type intercalated cells, without ultrastructural abnormalities in the endocytic apparatus.","method":"Immunohistochemistry of renal biopsies from eight Dent's disease patients with confirmed ClC-5 mutations","journal":"Kidney international","confidence":"Medium","confidence_rationale":"Tier 3 — direct immunohistochemical demonstration in patient biopsies with genotype confirmation","pmids":["12631345"],"is_preprint":false},{"year":2001,"finding":"CLC-5 in rat intestinal cells co-fractionates with the vacuolar H⁺-ATPase and the early endosomal GTPases Rab4 and Rab5a, localizing it to early endosomes in enterocytes, and partially co-localizes with the transcytosed polymeric immunoglobulin receptor.","method":"Western blotting; indirect immunofluorescence; subcellular fractionation with vesicle markers","journal":"American journal of physiology. Cell physiology","confidence":"Medium","confidence_rationale":"Tier 2 — fractionation with multiple markers in intestinal tissue, moderate evidence for endosomal localization","pmids":["11208533"],"is_preprint":false},{"year":2005,"finding":"ClC-5 knockout mice develop a euthyroid goiter with iodine accumulation and decreased pendrin (I⁻/Cl⁻ exchanger) expression (−60% at mRNA and protein levels). ClC-5 localizes to the apical pole of thyrocytes and best co-distributes with late endosomal marker Rab7. Loss of ClC-5 delays apical iodide efflux via pendrin downregulation rather than blocking apical endocytosis of thyroglobulin.","method":"ClC-5 KO mouse; thyroid 125I uptake assay; Percoll gradient fractionation; immunolocalization; RT-PCR and Western blot for pendrin","journal":"Endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 — KO mouse with multiple functional readouts and localization, single lab","pmids":["16306076"],"is_preprint":false},{"year":2010,"finding":"PY-motif-dependent ubiquitylation of ClC-5 (via WWP2/Nedd4-2 interaction) is dispensable for its role in proximal tubular endocytosis in vivo. Knock-in mice with destroyed PY-motif show no proteinuria or endocytic defects, unlike ClC-5 knockout mice. ClC-5 is unique among CLC proteins in being essential for proximal tubular endocytosis.","method":"Genetic knock-in mice (PY-motif point mutation); comparison with KO and double-KO mice lacking ClC-3 or ClC-4; receptor-mediated and fluid-phase endocytosis assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — clean genetic epistasis with multiple mouse models and functional endocytosis assays","pmids":["20351103"],"is_preprint":false},{"year":2012,"finding":"ClC-5 and megalin interact directly via their C-termini, and this interaction is scaffolded by NHERF2 in proximal tubule cells. NHERF2 silencing disrupts the ClC-5–megalin complex. A ternary complex of ClC-5, megalin, and NHERF2 was reconstituted with fusion proteins.","method":"GST pulldown; reciprocal co-immunoprecipitation from rat kidney lysate; siRNA against NHERF2; reconstitution of ternary complex with fusion proteins","journal":"The international journal of biochemistry & cell biology","confidence":"Medium","confidence_rationale":"Tier 2 — reciprocal co-IP from endogenous tissue combined with reconstitution and siRNA, single lab","pmids":["22349218"],"is_preprint":false},{"year":2012,"finding":"The gating glutamate Glu211 (external gate) is a major component of the gating charge underlying transient capacitive currents of ClC-5. Mutation E211D shifts transient currents ~150 mV to negative voltages. The gating mechanism involves intrinsic charge movement followed by voltage-dependent low-affinity binding of extracellular Cl⁻ ions.","method":"Two-electrode voltage clamp of transport-deficient E268A and E211D ClC-5 mutants in Xenopus oocytes; external and internal Cl⁻ and pH dependence analysis","journal":"Biophysical journal","confidence":"High","confidence_rationale":"Tier 1 — in vitro mutagenesis with quantitative biophysical analysis defining gating mechanism","pmids":["22824269"],"is_preprint":false},{"year":2013,"finding":"The strong outward rectification of ClC-5 currents is partly caused by a gating mechanism (not solely transport mechanism), identified through mutation D76H which reveals inward tail currents with 2:1 Cl⁻:H⁺ stoichiometry at negative potentials, allowing reversal potential estimation for the first time.","method":"Site-directed mutagenesis (D76H); two-electrode voltage clamp in Xenopus oocytes; external/internal pH and Cl⁻ concentration dependence","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 1 — in vitro mutagenesis with biophysical characterization defining gating vs. transport","pmids":["24099800"],"is_preprint":false},{"year":2005,"finding":"Several Dent's disease CLCN5 missense mutations fail to reach the plasma membrane and are retained in the ER/Golgi, indicating that correct channel structure is required for both function and Golgi exit. The R648X truncation mutant shows increased surface expression due to deletion of a C-terminal PY-like internalization signal.","method":"Heterologous expression in Xenopus oocytes and surface ELISA; two-electrode voltage-clamp analysis","journal":"Human genetics","confidence":"Medium","confidence_rationale":"Tier 2 — surface expression and functional assay in two systems, single lab","pmids":["15895257"],"is_preprint":false},{"year":2009,"finding":"Dent's disease CLCN5 mutations fall into distinct mechanistic classes: Type I mutations allow normal trafficking to cell surface and early endosomes but reduce ion currents; Type II mutations cause retention in the ER due to impaired N-glycosylation and protein misfolding.","method":"Heterologous expression in Xenopus oocytes and HEK293 cells; N-glycosylation analysis; surface expression assays; confocal localization with endosomal markers","journal":"Kidney international","confidence":"Medium","confidence_rationale":"Tier 2 — multiple mutations characterized by orthogonal methods in two expression systems","pmids":["19657328"],"is_preprint":false},{"year":2018,"finding":"A pathogenic gating-glutamate mutation (E211G) converts ClC-5 from a Cl⁻/H⁺ antiporter into a Cl⁻ channel (abolishes outward rectification and H⁺ sensitivity) while maintaining normal plasma membrane and early endosome localization and normal endosomal acidification, demonstrating that impaired endosomal acidification is not the sole parameter leading to defective endocytosis in Dent disease.","method":"Site-directed mutagenesis; two-electrode voltage clamp in Xenopus oocytes; HEK293T expression; endosomal pH measurement with pHluorin2 probe","journal":"Human mutation","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis with electrophysiology plus orthogonal pH measurement, directly tests mechanistic model","pmids":["29791050"],"is_preprint":false},{"year":2019,"finding":"ClC-5 exchanges 2 Cl⁻ out for 1 H⁺ in (2:1 stoichiometry confirmed by ion-selective microelectrodes). ClC-5 transport provides net negative charge acting as an 'on-off burst' shunting H⁺-ATPase during endosomal acidification. The S244L Dent mutation has slower transport and altered 1.6:1 stoichiometry; R345W traffics primarily to early endosomes in reduced quantity; Q629* is retained in ER/cis-Golgi.","method":"Ion-selective microelectrodes in Xenopus oocytes; organelle-specific fluorescent probes; chemiluminescent surface expression assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — quantitative stoichiometry measurements plus trafficking studies of multiple disease variants","pmids":["31852738"],"is_preprint":false},{"year":2006,"finding":"Disruption of clc-5 in collecting duct cells causes redistribution of annexin A2 from intracellular compartments to the plasma membrane, leading to increased cell-surface crystal retention and agglomeration of calcium phosphate and calcium oxalate crystals, which can be attenuated by anti-annexin A2 antibodies.","method":"Antisense clc-5 or truncated clc-5 overexpression in mIMCD-3 cells; immunofluorescence; crystal binding assay with antibody inhibition","journal":"Cellular and molecular life sciences : CMLS","confidence":"Medium","confidence_rationale":"Tier 3 — single lab, loss-of-function with specific mechanistic follow-up (antibody rescue)","pmids":["16429322"],"is_preprint":false},{"year":2006,"finding":"In ClC-5 KO mice, kidney-specific upregulation of 1,25(OH)₂-vitamin D₃ target genes occurs despite reduced serum 1,25(OH)₂-vitamin D₃, because impaired proximal tubular endocytosis of the vitamin D precursor leads to increased 1,25(OH)₂-vitamin D₃ in distal nephron segments, contributing to pathogenesis of Dent's disease.","method":"Expression profiling, qRT-PCR, and hormone measurements in ClC-5 KO vs. wild-type mice; tissue-specific analysis (kidney, intestine, bone)","journal":"Kidney international","confidence":"Medium","confidence_rationale":"Tier 2 — KO mouse with multiple quantitative measurements establishing kidney-specific pathway, single lab","pmids":["16672909"],"is_preprint":false},{"year":2018,"finding":"CLCN5 is expressed in human podocytes, and its knockdown impairs transferrin endocytosis, decreases cell proliferation, and increases cell migration. A Dent disease mutation (L521F) shows differential subcellular localization compared with wild-type ClC-5 in podocytes, implicating ClC-5 in podocyte protein trafficking and slit diaphragm integrity.","method":"CLCN5 knockdown in cultured human podocytes; transferrin endocytosis assay; cell migration/proliferation assays; transfection of L521F mutant with fluorescence localization","journal":"Kidney international reports","confidence":"Medium","confidence_rationale":"Tier 2 — multiple functional readouts in human podocyte cells with disease mutation, single lab","pmids":["30426109"],"is_preprint":false}],"current_model":"ClC-5 is an electrogenic 2Cl⁻/1H⁺ antiporter (not a passive Cl⁻ channel) resident in apical early endosomes of renal proximal tubule cells, where it provides Cl⁻ entry coupled to H⁺ export to facilitate H⁺-ATPase-driven endosomal acidification and Cl⁻ accumulation; its CBS domains bind nucleotides to regulate transport activity, its C-terminus interacts with cofilin, KIF3B, and megalin/NHERF2 scaffolds to coordinate vesicle trafficking and actin dynamics, and loss of ClC-5 function causes a trafficking defect of the endocytic receptors megalin and cubilin, severely impairing receptor-mediated endocytosis of low-molecular-weight proteins and producing the Dent disease phenotype."},"narrative":{"teleology":[{"year":1995,"claim":"The first demonstration that ClC-5 encodes a functional ion-conducting protein established it as a kidney-expressed chloride transporter with strong outward rectification, opening the question of its physiological role.","evidence":"Heterologous expression of rat ClC-5 in Xenopus oocytes with two-electrode voltage clamp","pmids":["8537381"],"confidence":"High","gaps":["Transport vs. channel mechanism unresolved","Subcellular localization unknown","No link to disease pathophysiology yet"]},{"year":1999,"claim":"Localization of ClC-5 to Rab4-positive early endosomes in proximal tubule cells and mutagenesis identifying key pore residues (S168, E211) redirected the field from plasma-membrane channel models toward an endosomal function.","evidence":"Subcellular fractionation of human kidney with immunoblotting; confocal co-localization; site-directed mutagenesis with electrophysiology in oocytes and HEK293 cells","pmids":["9931332","9873029"],"confidence":"High","gaps":["Functional consequence of endosomal localization not yet demonstrated","Whether endosomal acidification depends on ClC-5 untested"]},{"year":2000,"claim":"ClC-5 knockout mice recapitulated the Dent disease phenotype — low-molecular-weight proteinuria, aminoaciduria, and impaired proximal tubular endocytosis — establishing ClC-5 as essential for renal endocytic uptake in vivo.","evidence":"Targeted gene disruption in mice with HRP endocytosis assay and urinary biochemistry","pmids":["11115837"],"confidence":"High","gaps":["Molecular mechanism linking ClC-5 loss to endocytic failure unknown","Whether endosomal acidification is the primary defect unresolved"]},{"year":2002,"claim":"Endosomes from ClC-5 KO mice acidified more slowly than wild-type, directly demonstrating that ClC-5 provides a counter-ion conductance that facilitates H⁺-ATPase-driven acidification, and linking defective acidification to impaired PTH clearance and downstream phosphaturia.","evidence":"Endosomal acidification assay in KO vs. WT mice; PTH receptor and vitamin D pathway measurements","pmids":["12548389"],"confidence":"High","gaps":["Whether ClC-5 functions as a channel or antiporter still unknown","Relative contributions of acidification defect vs. other trafficking defects unclear"]},{"year":2003,"claim":"Multiple studies converged to show that ClC-5 loss causes selective mistrafficking of megalin and cubilin from the brush border, that its C-terminus interacts with cofilin to regulate actin dynamics during endocytosis, and that disease mutations disrupting CBS domain 2 prevent endosomal targeting — revealing that ClC-5 has both ion-transport and protein-scaffolding roles.","evidence":"ClC-5 KO mice with immunogold labeling and Percoll fractionation; yeast two-hybrid and GST pulldown for cofilin; confocal localization of CBS-truncation mutants; patient renal biopsies","pmids":["12815097","12904289","14521953","12631345"],"confidence":"High","gaps":["Whether cofilin interaction is direct in vivo or mediated by other factors","Structural basis of CBS domain role in trafficking unknown","Whether H⁺-ATPase mislocalization in patients is cause or consequence"]},{"year":2005,"claim":"The paradigm-shifting discovery that ClC-5 is a Cl⁻/H⁺ antiporter — not a passive Cl⁻ channel — fundamentally redefined its mechanism: it actively transports protons against their gradient, with the pore glutamate E211 serving as the proton-transfer residue.","evidence":"Extracellular pH measurements near cell surface in heterologous expression; E211A mutagenesis","pmids":["16034421"],"confidence":"High","gaps":["Stoichiometry not quantified","How antiport (rather than channel) function serves endosomal physiology not yet clear"]},{"year":2006,"claim":"CBS-domain crystallography revealed a specific ATP/ADP binding site that directly regulates ClC-5 transport, while in vivo studies linked ClC-5 loss to both renal crystal retention via annexin A2 redistribution and disordered vitamin D metabolism, broadening the phenotypic consequences beyond proteinuria.","evidence":"X-ray crystallography of CBS domain with nucleotides plus oocyte electrophysiology; ClC-5 KO mice with crystal binding and vitamin D pathway measurements; antisense in mIMCD-3 cells","pmids":["17195847","16429322","16672909"],"confidence":"High","gaps":["How nucleotide binding allosterically alters transport cycle unknown","Whether crystal retention contributes to nephrolithiasis in Dent patients unconfirmed"]},{"year":2009,"claim":"Quantification of the 2Cl⁻:1H⁺ antiport stoichiometry, identification of intracellular proton activation (pK ~7.2), discovery of the KIF3B motor interaction, and classification of Dent mutations into trafficking-defective vs. transport-defective classes together built a comprehensive mechanistic framework.","evidence":"Extracellular proton imaging in oocytes; S168P mutagenesis; yeast two-hybrid and endogenous co-IP for KIF3B with live imaging; surface expression and glycosylation analysis of disease mutants","pmids":["19131966","19940036","19657328"],"confidence":"High","gaps":["Whether KIF3B interaction is essential for endosomal delivery in vivo untested","Structural basis of the 2:1 stoichiometry not resolved"]},{"year":2010,"claim":"PY-motif-dependent ubiquitylation by Nedd4-2/WWP2 was shown to be dispensable for ClC-5's endocytic function in vivo, and ClC-5 was uniquely required among CLC family members for proximal tubular endocytosis, eliminating redundancy models.","evidence":"Genetic knock-in mice (PY-motif mutation) compared with KO and ClC-3/ClC-4 double-KO mice; receptor-mediated and fluid-phase endocytosis assays","pmids":["20351103"],"confidence":"High","gaps":["Which internalization/recycling signals besides PY-motif regulate ClC-5 surface expression","Why ClC-3 and ClC-4 cannot compensate despite shared localization"]},{"year":2012,"claim":"Identification of the ClC-5–megalin–NHERF2 ternary complex and elucidation of the E211 gating glutamate as the major charge-carrying residue in transient capacitive currents established that ClC-5 physically scaffolds the endocytic receptor and that its gating involves intrinsic charge movement prior to Cl⁻ binding.","evidence":"Reciprocal co-IP from rat kidney, NHERF2 siRNA, ternary complex reconstitution; voltage clamp of E211D and E268A mutants in oocytes","pmids":["22349218","22824269"],"confidence":"High","gaps":["Whether NHERF2 disruption in vivo recapitulates Dent phenotype untested","Full gating model lacking structural data on transmembrane conformational changes"]},{"year":2018,"claim":"The E211G mutation, which converts ClC-5 from antiporter to pure Cl⁻ channel while preserving normal trafficking and endosomal acidification, demonstrated that coupled H⁺ transport is required for endocytosis through a mechanism beyond simple pH regulation — a key conceptual advance separating the ion-coupling mode from acidification per se.","evidence":"Mutagenesis with electrophysiology in oocytes; endosomal pH measurement with pHluorin2 in HEK293T cells","pmids":["29791050"],"confidence":"High","gaps":["What downstream process requires the antiport mode specifically (e.g. Cl⁻ accumulation, endosomal voltage) remains unidentified","Whether this applies in proximal tubule cells in vivo not tested"]},{"year":2019,"claim":"Ion-selective microelectrode measurements confirmed the 2:1 Cl⁻:H⁺ stoichiometry and revealed that ClC-5 operates in burst mode, while disease mutant S244L showed altered stoichiometry (1.6:1), directly linking stoichiometric fidelity to disease pathogenesis.","evidence":"Ion-selective microelectrodes in Xenopus oocytes; organelle fluorescent probes; multiple Dent mutant characterization","pmids":["31852738"],"confidence":"High","gaps":["How altered stoichiometry causes endocytic failure mechanistically unclear","No high-resolution structure of full-length mammalian ClC-5 available"]},{"year":null,"claim":"The key unresolved question is why the antiport coupling mode — rather than simple Cl⁻ conductance — is essential for endocytosis, and whether this reflects a requirement for endosomal Cl⁻ accumulation, specific membrane voltage, or signaling to the megalin–cubilin trafficking machinery.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No high-resolution structure of full-length ClC-5 in a lipid membrane","The specific downstream effector of antiport-mode coupling in endocytosis is unidentified","Whether ClC-5's scaffolding interactions (cofilin, KIF3B, NHERF2-megalin) are independently essential or cooperative in vivo is untested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,1,3,17,18,22]}],"localization":[{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[5,7,11,13]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[1,2,19,22]}],"pathway":[{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[5,6,7,8,10,15]},{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[0,3,22]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[6,7,12,20,21]}],"complexes":["ClC-5–megalin–NHERF2 ternary complex"],"partners":["LRP2","NHERF2","KIF3B","CFL1","ANXA2"],"other_free_text":[]},"mechanistic_narrative":"CLCN5 encodes ClC-5, an electrogenic 2Cl⁻/1H⁺ antiporter predominantly localized to early endosomes of renal proximal tubule cells, where it provides an electrical shunt for the vacuolar H⁺-ATPase to drive endosomal acidification and support receptor-mediated endocytosis [PMID:16034421, PMID:19131966, PMID:9931332, PMID:12548389]. ClC-5 transport activity is regulated by intracellular protons and by ATP/ADP binding to its cytoplasmic CBS domains; its C-terminus physically interacts with cofilin, KIF3B, and a megalin–NHERF2 scaffold complex, coupling vesicle trafficking, actin dynamics, and endocytic receptor positioning [PMID:17195847, PMID:12904289, PMID:19940036, PMID:22349218]. Loss of ClC-5 in knockout mice causes defective trafficking of the endocytic receptors megalin and cubilin, severely impairing proximal tubular uptake of low-molecular-weight proteins and producing proteinuria, aminoaciduria, hypercalciuria, and disordered vitamin D metabolism characteristic of Dent disease [PMID:11115837, PMID:12815097, PMID:16672909]. Dent disease–causing CLCN5 mutations act through distinct mechanisms: some abolish ion transport while preserving trafficking, and others cause ER retention due to protein misfolding, while conversion to a pure Cl⁻ channel (E211G) demonstrates that the coupled H⁺ transport mode itself is required for normal endocytosis beyond simple acidification [PMID:19657328, PMID:29791050]."},"prefetch_data":{"uniprot":{"accession":"P51795","full_name":"H(+)/Cl(-) exchange transporter 5","aliases":["Chloride channel protein 5","ClC-5","Chloride transporter ClC-5"],"length_aa":816,"mass_kda":90.8,"function":"Proton-coupled chloride transporter. Functions as antiport system and exchanges chloride ions against protons (PubMed:20466723). Important for normal acidification of the endosome lumen. May play an important role in renal tubular function. The CLC channel family contains both chloride channels and proton-coupled anion transporters that exchange chloride or another anion for protons. The absence of conserved gating glutamate residues is typical for family members that function as channels (Probable)","subcellular_location":"Golgi apparatus membrane; Endosome membrane; Cell membrane","url":"https://www.uniprot.org/uniprotkb/P51795/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CLCN5","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"VTI1A","stoichiometry":4.0},{"gene":"RAB7A","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/CLCN5","total_profiled":1310},"omim":[{"mim_id":"430000","title":"INTERLEUKIN 3 RECEPTOR, Y-CHROMOSOMAL; IL3RA","url":"https://www.omim.org/entry/430000"},{"mim_id":"314310","title":"TRANSCRIPTION FACTOR FOR IMMUNOGLOBULIN HEAVY-CHAIN ENHANCER 3; TFE3","url":"https://www.omim.org/entry/314310"},{"mim_id":"310468","title":"NEPHROLITHIASIS, X-LINKED RECESSIVE, WITH RENAL FAILURE; XRN","url":"https://www.omim.org/entry/310468"},{"mim_id":"308990","title":"PROTEINURIA, LOW MOLECULAR WEIGHT, WITH HYPERCALCIURIA AND NEPHROCALCINOSIS","url":"https://www.omim.org/entry/308990"},{"mim_id":"300555","title":"DENT DISEASE 2; DENT2","url":"https://www.omim.org/entry/300555"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Golgi apparatus","reliability":"Supported"},{"location":"Plasma membrane","reliability":"Supported"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"epididymis","ntpm":22.3},{"tissue":"kidney","ntpm":43.1},{"tissue":"liver","ntpm":15.8}],"url":"https://www.proteinatlas.org/search/CLCN5"},"hgnc":{"alias_symbol":["DENTS","XLRH","hClC-K2","hCIC-K2","CLC5","XRN","ClC-5"],"prev_symbol":["NPHL2","NPHL1"]},"alphafold":{"accession":"P51795","domains":[{"cath_id":"1.10.3080.10","chopping":"131-364","consensus_level":"medium","plddt":89.2516,"start":131,"end":364},{"cath_id":"1.10.3080.10","chopping":"389-473_487-634","consensus_level":"high","plddt":88.908,"start":389,"end":634},{"cath_id":"3.10.580.20","chopping":"651-805","consensus_level":"high","plddt":86.6072,"start":651,"end":805}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P51795","model_url":"https://alphafold.ebi.ac.uk/files/AF-P51795-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P51795-F1-predicted_aligned_error_v6.png","plddt_mean":80.62},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CLCN5","jax_strain_url":"https://www.jax.org/strain/search?query=CLCN5"},"sequence":{"accession":"P51795","fasta_url":"https://rest.uniprot.org/uniprotkb/P51795.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P51795/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P51795"}},"corpus_meta":[{"pmid":"16034421","id":"PMC_16034421","title":"Chloride/proton antiporter activity of mammalian CLC proteins ClC-4 and ClC-5.","date":"2005","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/16034421","citation_count":376,"is_preprint":false},{"pmid":"7922301","id":"PMC_7922301","title":"Dent's disease; a familial proximal renal tubular syndrome with low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, metabolic bone disease, progressive renal failure and a marked male predominance.","date":"1994","source":"QJM : monthly journal of the Association of Physicians","url":"https://pubmed.ncbi.nlm.nih.gov/7922301","citation_count":257,"is_preprint":false},{"pmid":"12815097","id":"PMC_12815097","title":"Loss of chloride channel ClC-5 impairs endocytosis by defective trafficking of megalin and cubilin in kidney proximal tubules.","date":"2003","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12815097","citation_count":254,"is_preprint":false},{"pmid":"11115837","id":"PMC_11115837","title":"Mice lacking renal chloride channel, CLC-5, are a model for Dent's disease, a nephrolithiasis disorder associated with defective receptor-mediated endocytosis.","date":"2000","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11115837","citation_count":247,"is_preprint":false},{"pmid":"9931332","id":"PMC_9931332","title":"Intra-renal and subcellular distribution of the human chloride channel, CLC-5, reveals a pathophysiological basis for Dent's disease.","date":"1999","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9931332","citation_count":239,"is_preprint":false},{"pmid":"8537381","id":"PMC_8537381","title":"Cloning and functional expression of rat CLC-5, a chloride channel related to kidney disease.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8537381","citation_count":238,"is_preprint":false},{"pmid":"9873029","id":"PMC_9873029","title":"Mutational analysis demonstrates that ClC-4 and ClC-5 directly mediate plasma membrane currents.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9873029","citation_count":208,"is_preprint":false},{"pmid":"20946626","id":"PMC_20946626","title":"Dent's disease.","date":"2010","source":"Orphanet journal of rare diseases","url":"https://pubmed.ncbi.nlm.nih.gov/20946626","citation_count":167,"is_preprint":false},{"pmid":"12548389","id":"PMC_12548389","title":"The ClC-5 chloride channel knock-out mouse - an animal model for Dent's disease.","date":"2002","source":"Pflugers Archiv : European journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12548389","citation_count":159,"is_preprint":false},{"pmid":"9259268","id":"PMC_9259268","title":"Characterisation of renal chloride channel, CLCN5, mutations in hypercalciuric nephrolithiasis (kidney stones) disorders.","date":"1997","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9259268","citation_count":134,"is_preprint":false},{"pmid":"7874126","id":"PMC_7874126","title":"Isolation and partial characterization of a chloride channel gene which is expressed in kidney and is a candidate for Dent's disease (an X-linked hereditary nephrolithiasis).","date":"1994","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/7874126","citation_count":134,"is_preprint":false},{"pmid":"17195847","id":"PMC_17195847","title":"Nucleotide recognition by the cytoplasmic domain of the human chloride transporter ClC-5.","date":"2006","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17195847","citation_count":128,"is_preprint":false},{"pmid":"8575751","id":"PMC_8575751","title":"Cloning and characterization of CLCN5, the human kidney chloride channel gene implicated in Dent disease (an X-linked hereditary nephrolithiasis).","date":"1995","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8575751","citation_count":124,"is_preprint":false},{"pmid":"9062355","id":"PMC_9062355","title":"Idiopathic low molecular weight proteinuria associated with hypercalciuric nephrocalcinosis in Japanese children is due to mutations of the renal chloride channel (CLCN5).","date":"1997","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/9062355","citation_count":121,"is_preprint":false},{"pmid":"10620205","id":"PMC_10620205","title":"Tubular proteinuria defined by a study of Dent's (CLCN5 mutation) and other tubular diseases.","date":"2000","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/10620205","citation_count":86,"is_preprint":false},{"pmid":"8111383","id":"PMC_8111383","title":"Dent's disease, a renal Fanconi syndrome with nephrocalcinosis and kidney stones, is associated with a microdeletion involving DXS255 and maps to Xp11.22.","date":"1993","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8111383","citation_count":84,"is_preprint":false},{"pmid":"19131966","id":"PMC_19131966","title":"Conversion of the 2 Cl(-)/1 H+ antiporter ClC-5 in a NO3(-)/H+ antiporter by a single point mutation.","date":"2009","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/19131966","citation_count":82,"is_preprint":false},{"pmid":"10720930","id":"PMC_10720930","title":"Pathogenesis of Dent's disease and related syndromes of X-linked nephrolithiasis.","date":"2000","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/10720930","citation_count":78,"is_preprint":false},{"pmid":"20936522","id":"PMC_20936522","title":"Dent's disease: clinical features and molecular basis.","date":"2010","source":"Pediatric nephrology (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/20936522","citation_count":78,"is_preprint":false},{"pmid":"12904289","id":"PMC_12904289","title":"Cofilin interacts with ClC-5 and regulates albumin uptake in proximal tubule cell lines.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12904289","citation_count":77,"is_preprint":false},{"pmid":"25907713","id":"PMC_25907713","title":"Mutation Update of the CLCN5 Gene Responsible for Dent Disease 1.","date":"2015","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/25907713","citation_count":74,"is_preprint":false},{"pmid":"12631345","id":"PMC_12631345","title":"Altered polarity and expression of H+-ATPase without ultrastructural changes in kidneys of Dent's disease patients.","date":"2003","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/12631345","citation_count":67,"is_preprint":false},{"pmid":"9853249","id":"PMC_9853249","title":"Functional characterization of renal chloride channel, CLCN5, mutations associated with Dent'sJapan disease.","date":"1998","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/9853249","citation_count":66,"is_preprint":false},{"pmid":"11208533","id":"PMC_11208533","title":"Tissue distribution and subcellular localization of the ClC-5 chloride channel in rat intestinal cells.","date":"2001","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11208533","citation_count":66,"is_preprint":false},{"pmid":"16306076","id":"PMC_16306076","title":"The loss of the chloride channel, ClC-5, delays apical iodide efflux and induces a euthyroid goiter in the mouse thyroid gland.","date":"2005","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/16306076","citation_count":65,"is_preprint":false},{"pmid":"9449697","id":"PMC_9449697","title":"The swelling-activated chloride channel ClC-2, the chloride channel ClC-3, and ClC-5, a chloride channel mutated in kidney stone disease, are expressed in distinct subpopulations of renal epithelial cells.","date":"1998","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/9449697","citation_count":65,"is_preprint":false},{"pmid":"9328929","id":"PMC_9328929","title":"Mutations of CLCN5 in Japanese children with idiopathic low molecular weight proteinuria, hypercalciuria and nephrocalcinosis.","date":"1997","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/9328929","citation_count":64,"is_preprint":false},{"pmid":"22695891","id":"PMC_22695891","title":"Mutational analysis of PHEX, FGF23, DMP1, SLC34A3 and CLCN5 in patients with hypophosphatemic rickets.","date":"2012","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22695891","citation_count":63,"is_preprint":false},{"pmid":"9815133","id":"PMC_9815133","title":"Intrarenal and subcellular localization of rat CLC5.","date":"1998","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/9815133","citation_count":56,"is_preprint":false},{"pmid":"9734595","id":"PMC_9734595","title":"CLCN5 chloride-channel mutations in six new North American families with X-linked nephrolithiasis.","date":"1998","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/9734595","citation_count":56,"is_preprint":false},{"pmid":"10518595","id":"PMC_10518595","title":"Diet-dependent hypercalciuria in transgenic mice with reduced CLC5 chloride channel expression.","date":"1999","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/10518595","citation_count":55,"is_preprint":false},{"pmid":"9596078","id":"PMC_9596078","title":"Mutations in CLCN5 chloride channel in Japanese patients with low molecular weight proteinuria.","date":"1998","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/9596078","citation_count":52,"is_preprint":false},{"pmid":"19940036","id":"PMC_19940036","title":"CLC-5 and KIF3B interact to facilitate CLC-5 plasma membrane expression, endocytosis, and microtubular transport: relevance to pathophysiology of Dent's disease.","date":"2009","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/19940036","citation_count":51,"is_preprint":false},{"pmid":"14521953","id":"PMC_14521953","title":"A role for CBS domain 2 in trafficking of chloride channel CLC-5.","date":"2003","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/14521953","citation_count":50,"is_preprint":false},{"pmid":"10620204","id":"PMC_10620204","title":"Isolated hypercalciuria with mutation in CLCN5: relevance to idiopathic hypercalciuria.","date":"2000","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/10620204","citation_count":47,"is_preprint":false},{"pmid":"15895257","id":"PMC_15895257","title":"Functional evaluation of Dent's disease-causing mutations: implications for ClC-5 channel trafficking and internalization.","date":"2005","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15895257","citation_count":47,"is_preprint":false},{"pmid":"25909590","id":"PMC_25909590","title":"IL-4 Up-Regulates MiR-21 and the MiRNAs Hosted in the CLCN5 Gene in Chronic Lymphocytic Leukemia.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25909590","citation_count":46,"is_preprint":false},{"pmid":"10906159","id":"PMC_10906159","title":"Characterization of renal chloride channel (CLCN5) mutations in Dent's disease.","date":"2000","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/10906159","citation_count":46,"is_preprint":false},{"pmid":"22083641","id":"PMC_22083641","title":"ClC-5 mutations associated with Dent's disease: a major role of the dimer interface.","date":"2011","source":"Pflugers Archiv : European journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/22083641","citation_count":45,"is_preprint":false},{"pmid":"10191359","id":"PMC_10191359","title":"Comparison of amphibian and human ClC-5: similarity of functional properties and inhibition by external pH.","date":"1999","source":"The Journal of membrane biology","url":"https://pubmed.ncbi.nlm.nih.gov/10191359","citation_count":42,"is_preprint":false},{"pmid":"20351103","id":"PMC_20351103","title":"Role of ClC-5 in renal endocytosis is unique among ClC exchangers and does not require PY-motif-dependent ubiquitylation.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20351103","citation_count":41,"is_preprint":false},{"pmid":"16807762","id":"PMC_16807762","title":"Hypercalciuria in patients with CLCN5 mutations.","date":"2006","source":"Pediatric nephrology (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/16807762","citation_count":39,"is_preprint":false},{"pmid":"10916075","id":"PMC_10916075","title":"Clinical and genetic studies of CLCN5 mutations in Japanese families with Dent's disease.","date":"2000","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/10916075","citation_count":39,"is_preprint":false},{"pmid":"9328927","id":"PMC_9328927","title":"Mutations in the CLCN5 gene in Japanese patients with familial idiopathic low-molecular-weight proteinuria.","date":"1997","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/9328927","citation_count":39,"is_preprint":false},{"pmid":"19657328","id":"PMC_19657328","title":"Novel CLCN5 mutations in patients with Dent's disease result in altered ion currents or impaired exchanger processing.","date":"2009","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/19657328","citation_count":38,"is_preprint":false},{"pmid":"20680351","id":"PMC_20680351","title":"A novel CLCN5 mutation in a boy with Bartter-like syndrome and partial growth hormone deficiency.","date":"2010","source":"Pediatric nephrology (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/20680351","citation_count":34,"is_preprint":false},{"pmid":"15637424","id":"PMC_15637424","title":"Chloride channels and endocytosis: new insights from Dent's disease and ClC-5 knockout mice.","date":"2005","source":"Nephron. Physiology","url":"https://pubmed.ncbi.nlm.nih.gov/15637424","citation_count":33,"is_preprint":false},{"pmid":"12637640","id":"PMC_12637640","title":"Novel truncating mutations in the ClC-5 chloride channel gene in patients with Dent's disease.","date":"2003","source":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association","url":"https://pubmed.ncbi.nlm.nih.gov/12637640","citation_count":33,"is_preprint":false},{"pmid":"9452997","id":"PMC_9452997","title":"CLCN5 mutation Ser244Leu is associated with X-linked renal failure without X-linked recessive hypophosphatemic rickets.","date":"1998","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/9452997","citation_count":33,"is_preprint":false},{"pmid":"32289351","id":"PMC_32289351","title":"From protein uptake to Dent disease: An overview of the CLCN5 gene.","date":"2020","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/32289351","citation_count":32,"is_preprint":false},{"pmid":"15956597","id":"PMC_15956597","title":"Characterization of a novel vpu-harboring simian immunodeficiency virus from a Dent's Mona monkey (Cercopithecus mona denti).","date":"2005","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/15956597","citation_count":32,"is_preprint":false},{"pmid":"26389017","id":"PMC_26389017","title":"Nephrolithiasis, kidney failure and bone disorders in Dent disease patients with and without CLCN5 mutations.","date":"2015","source":"SpringerPlus","url":"https://pubmed.ncbi.nlm.nih.gov/26389017","citation_count":31,"is_preprint":false},{"pmid":"11136179","id":"PMC_11136179","title":"Identification of two novel mutations in the CLCN5 gene in Japanese patients with familial idiopathic low molecular weight proteinuria (Japanese Dent's disease).","date":"2001","source":"American journal of kidney diseases : the official journal of the National Kidney Foundation","url":"https://pubmed.ncbi.nlm.nih.gov/11136179","citation_count":31,"is_preprint":false},{"pmid":"20576581","id":"PMC_20576581","title":"Cadmium impairs albumin reabsorption by down-regulating megalin and ClC5 channels in renal proximal tubule cells.","date":"2010","source":"Environmental health perspectives","url":"https://pubmed.ncbi.nlm.nih.gov/20576581","citation_count":30,"is_preprint":false},{"pmid":"14569459","id":"PMC_14569459","title":"De novo insertion of an Alu sequence in the coding region of the CLCN5 gene results in Dent's disease.","date":"2003","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14569459","citation_count":30,"is_preprint":false},{"pmid":"16429322","id":"PMC_16429322","title":"Disruption of clc-5 leads to a redistribution of annexin A2 and promotes calcium crystal agglomeration in collecting duct epithelial cells.","date":"2006","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/16429322","citation_count":30,"is_preprint":false},{"pmid":"10469281","id":"PMC_10469281","title":"Renal chloride channel, CLCN5, mutations in Dent's disease.","date":"1999","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/10469281","citation_count":29,"is_preprint":false},{"pmid":"16041495","id":"PMC_16041495","title":"The Alu insertion in the CLCN5 gene of a patient with Dent's disease leads to exon 11 skipping.","date":"2005","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16041495","citation_count":29,"is_preprint":false},{"pmid":"22824269","id":"PMC_22824269","title":"On the mechanism of gating charge movement of ClC-5, a human Cl(-)/H(+) antiporter.","date":"2012","source":"Biophysical journal","url":"https://pubmed.ncbi.nlm.nih.gov/22824269","citation_count":29,"is_preprint":false},{"pmid":"19546591","id":"PMC_19546591","title":"Mutational analysis of CLC-5, cofilin and CLC-4 in patients with Dent's disease.","date":"2009","source":"Nephron. Physiology","url":"https://pubmed.ncbi.nlm.nih.gov/19546591","citation_count":28,"is_preprint":false},{"pmid":"18349385","id":"PMC_18349385","title":"Transcriptional adaptation to Clcn5 knockout in proximal tubules of mouse kidney.","date":"2008","source":"Physiological genomics","url":"https://pubmed.ncbi.nlm.nih.gov/18349385","citation_count":27,"is_preprint":false},{"pmid":"21305656","id":"PMC_21305656","title":"Heterogeneity in the processing of CLCN5 mutants related to Dent disease.","date":"2011","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/21305656","citation_count":26,"is_preprint":false},{"pmid":"19582483","id":"PMC_19582483","title":"Locus heterogeneity of Dent's disease: OCRL1 and TMEM27 genes in patients with no CLCN5 mutations.","date":"2009","source":"Pediatric nephrology (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/19582483","citation_count":26,"is_preprint":false},{"pmid":"21932010","id":"PMC_21932010","title":"A patient with Dent disease and features of Bartter syndrome caused by a novel mutation of CLCN5.","date":"2011","source":"European journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/21932010","citation_count":26,"is_preprint":false},{"pmid":"9187673","id":"PMC_9187673","title":"A second family with XLRH displays the mutation S244L in the CLCN5 gene.","date":"1997","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9187673","citation_count":26,"is_preprint":false},{"pmid":"25443653","id":"PMC_25443653","title":"ClC-5: Physiological role and biophysical mechanisms.","date":"2014","source":"Cell calcium","url":"https://pubmed.ncbi.nlm.nih.gov/25443653","citation_count":25,"is_preprint":false},{"pmid":"16672909","id":"PMC_16672909","title":"Kidney-specific upregulation of vitamin D3 target genes in ClC-5 KO mice.","date":"2006","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/16672909","citation_count":25,"is_preprint":false},{"pmid":"30426109","id":"PMC_30426109","title":"A Novel CLCN5 Mutation Associated With Focal Segmental Glomerulosclerosis and Podocyte Injury.","date":"2018","source":"Kidney international reports","url":"https://pubmed.ncbi.nlm.nih.gov/30426109","citation_count":24,"is_preprint":false},{"pmid":"28383812","id":"PMC_28383812","title":"Mutational analysis of PHEX, FGF23 and CLCN5 in patients with hypophosphataemic rickets.","date":"2017","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/28383812","citation_count":24,"is_preprint":false},{"pmid":"22349218","id":"PMC_22349218","title":"The interaction between megalin and ClC-5 is scaffolded by the Na⁺-H⁺ exchanger regulatory factor 2 (NHERF2) in proximal tubule cells.","date":"2012","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/22349218","citation_count":24,"is_preprint":false},{"pmid":"11263994","id":"PMC_11263994","title":"Expression of chloride channel, ClC-5, and its role in receptor-mediated endocytosis of albumin in OK cells.","date":"2001","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11263994","citation_count":23,"is_preprint":false},{"pmid":"15047167","id":"PMC_15047167","title":"Expression and roles of Cl- channel ClC-5 in cell cycles of myeloid cells.","date":"2004","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15047167","citation_count":22,"is_preprint":false},{"pmid":"9893114","id":"PMC_9893114","title":"Chloride channel CLCN5 mutations in Japanese children with familial idiopathic low molecular weight proteinuria.","date":"1999","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/9893114","citation_count":22,"is_preprint":false},{"pmid":"23047739","id":"PMC_23047739","title":"An atypical Dent's disease phenotype caused by co-inheritance of mutations at CLCN5 and OCRL genes.","date":"2012","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/23047739","citation_count":22,"is_preprint":false},{"pmid":"21063094","id":"PMC_21063094","title":"Role of CFTR and ClC-5 in modulating vacuolar H+-ATPase activity in kidney proximal tubule.","date":"2010","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/21063094","citation_count":22,"is_preprint":false},{"pmid":"14675051","id":"PMC_14675051","title":"Comparative ontogeny, processing, and segmental distribution of the renal chloride channel, ClC-5.","date":"2004","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/14675051","citation_count":21,"is_preprint":false},{"pmid":"29791050","id":"PMC_29791050","title":"A novel CLCN5 pathogenic mutation supports Dent disease with normal endosomal acidification.","date":"2018","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/29791050","citation_count":21,"is_preprint":false},{"pmid":"28676554","id":"PMC_28676554","title":"Diabetic rats present higher urinary loss of proteins and lower renal expression of megalin, cubilin, ClC-5, and CFTR.","date":"2017","source":"Physiological reports","url":"https://pubmed.ncbi.nlm.nih.gov/28676554","citation_count":21,"is_preprint":false},{"pmid":"24099800","id":"PMC_24099800","title":"A single point mutation reveals gating of the human ClC-5 Cl-/H+ antiporter.","date":"2013","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/24099800","citation_count":20,"is_preprint":false},{"pmid":"18025833","id":"PMC_18025833","title":"Functional characterization of a novel missense CLCN5 mutation causing alterations in proximal tubular endocytic machinery in Dent's disease.","date":"2007","source":"Nephron. Physiology","url":"https://pubmed.ncbi.nlm.nih.gov/18025833","citation_count":20,"is_preprint":false},{"pmid":"13679301","id":"PMC_13679301","title":"Coexpression of complementary fragments of ClC-5 and restoration of chloride channel function in a Dent's disease mutation.","date":"2003","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/13679301","citation_count":20,"is_preprint":false},{"pmid":"28899456","id":"PMC_28899456","title":"ClC5 Decreases the Sensitivity of Multiple Myeloma Cells to Bortezomib via Promoting Prosurvival Autophagy.","date":"2017","source":"Oncology research","url":"https://pubmed.ncbi.nlm.nih.gov/28899456","citation_count":20,"is_preprint":false},{"pmid":"20181886","id":"PMC_20181886","title":"Clcn5 knockout mice exhibit novel immunomodulatory effects and are more susceptible to dextran sulfate sodium-induced colitis.","date":"2010","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/20181886","citation_count":19,"is_preprint":false},{"pmid":"21927812","id":"PMC_21927812","title":"Decreased renal accumulation of aminoglycoside reflects defective receptor-mediated endocytosis in cystic fibrosis and Dent's disease.","date":"2011","source":"Pflugers Archiv : European journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/21927812","citation_count":19,"is_preprint":false},{"pmid":"37284679","id":"PMC_37284679","title":"The Site and Type of CLCN5 Genetic Variation Impact the Resulting Dent Disease-1 Phenotype.","date":"2023","source":"Kidney international reports","url":"https://pubmed.ncbi.nlm.nih.gov/37284679","citation_count":18,"is_preprint":false},{"pmid":"26603451","id":"PMC_26603451","title":"Chloride-hydrogen antiporters ClC-3 and ClC-5 drive osteoblast mineralization and regulate fine-structure bone patterning in vitro.","date":"2015","source":"Physiological reports","url":"https://pubmed.ncbi.nlm.nih.gov/26603451","citation_count":18,"is_preprint":false},{"pmid":"31947599","id":"PMC_31947599","title":"Genetic Analyses in Dent Disease and Characterization of CLCN5 Mutations in Kidney Biopsies.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31947599","citation_count":17,"is_preprint":false},{"pmid":"11691871","id":"PMC_11691871","title":"The voltage-dependent Cl(-) channel ClC-5 and plasma membrane Cl(-) conductances of mouse renal collecting duct cells (mIMCD-3).","date":"2001","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11691871","citation_count":17,"is_preprint":false},{"pmid":"19878925","id":"PMC_19878925","title":"ClC-5 regulates dentin development through TGF-beta1 pathway.","date":"2009","source":"Archives of oral biology","url":"https://pubmed.ncbi.nlm.nih.gov/19878925","citation_count":16,"is_preprint":false},{"pmid":"20049483","id":"PMC_20049483","title":"ClC transporters: discoveries and challenges in defining the mechanisms underlying function and regulation of ClC-5.","date":"2010","source":"Pflugers Archiv : European journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/20049483","citation_count":16,"is_preprint":false},{"pmid":"14673707","id":"PMC_14673707","title":"Identification of a novel splice site mutation of CLCN5 gene and characterization of a new alternative 5' UTR end of ClC-5 mRNA in human renal tissue and leukocytes.","date":"2003","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14673707","citation_count":16,"is_preprint":false},{"pmid":"26036722","id":"PMC_26036722","title":"A tale of two CLCs: biophysical insights toward understanding ClC-5 and ClC-7 function in endosomes and lysosomes.","date":"2015","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/26036722","citation_count":15,"is_preprint":false},{"pmid":"27117801","id":"PMC_27117801","title":"Functional and transport analyses of CLCN5 genetic changes identified in Dent disease patients.","date":"2016","source":"Physiological reports","url":"https://pubmed.ncbi.nlm.nih.gov/27117801","citation_count":15,"is_preprint":false},{"pmid":"30852663","id":"PMC_30852663","title":"Prevalence of low molecular weight proteinuria and Dent disease 1 CLCN5 mutations in proteinuric cohorts.","date":"2019","source":"Pediatric nephrology (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/30852663","citation_count":15,"is_preprint":false},{"pmid":"12886045","id":"PMC_12886045","title":"Four additional CLCN5 exons encode a widely expressed novel long CLC-5 isoform but fail to explain Dent's phenotype in patients without mutations in the short variant.","date":"2003","source":"Kidney & blood pressure research","url":"https://pubmed.ncbi.nlm.nih.gov/12886045","citation_count":15,"is_preprint":false},{"pmid":"31852738","id":"PMC_31852738","title":"Cl- and H+ coupling properties and subcellular localizations of wildtype and disease-associated variants of the voltage-gated Cl-/H+ exchanger ClC-5.","date":"2019","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31852738","citation_count":15,"is_preprint":false},{"pmid":"11167024","id":"PMC_11167024","title":"Isolation and characterization of the human CLC-5 chloride channel gene promoter.","date":"2000","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/11167024","citation_count":15,"is_preprint":false},{"pmid":"17262170","id":"PMC_17262170","title":"A missense mutation in the chloride/proton ClC-5 antiporter gene results in increased expression of an alternative mRNA form that lacks exons 10 and 11. Identification of seven new CLCN5 mutations in patients with Dent's disease.","date":"2007","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17262170","citation_count":15,"is_preprint":false},{"pmid":"15158917","id":"PMC_15158917","title":"Calcium phosphate and calcium oxalate crystal handling is dependent upon CLC-5 expression in mouse collecting duct cells.","date":"2004","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/15158917","citation_count":15,"is_preprint":false},{"pmid":"22350370","id":"PMC_22350370","title":"Vitamin A deficiency associated with urinary retinol binding protein wasting in Dent's disease.","date":"2012","source":"Pediatric nephrology (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/22350370","citation_count":15,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51468,"output_tokens":6253,"usd":0.1241},"stage2":{"model":"claude-opus-4-6","input_tokens":9894,"output_tokens":3491,"usd":0.205118},"total_usd":0.329218,"stage1_batch_id":"msgbatch_011kfMfE81o6CTcyhVUqumuW","stage2_batch_id":"msgbatch_01DTputS6WNkH745x1nVSoBo","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2005,\n      \"finding\": \"ClC-5 is a Cl⁻/H⁺ antiporter (secondary active transporter), not a classical Cl⁻ channel. It carries protons across the plasma membrane when activated by positive voltages, and can extrude protons against their electrochemical gradient. The pore glutamate E211A mutation abolishes H⁺ transport but not Cl⁻ transport, demonstrating that this residue is critical for proton coupling.\",\n      \"method\": \"Extracellular pH measurements near cell surface in heterologous expression system; site-directed mutagenesis of pore glutamate (E211A)\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro functional assay with mutagenesis, high-citation foundational paper replicated by subsequent studies\",\n      \"pmids\": [\"16034421\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Rat CLC-5 expressed in Xenopus oocytes elicits strongly outwardly rectifying anion currents with conductivity sequence NO₃⁻ > Cl⁻ > Br⁻ > I⁻ >> glutamate⁻, establishing it as a functional ion channel/transporter. Expression is predominantly in kidney.\",\n      \"method\": \"Heterologous expression in Xenopus oocytes; electrophysiology\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution in oocytes, foundational paper with 238 citations\",\n      \"pmids\": [\"8537381\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"ClC-4 and ClC-5 directly mediate plasma membrane currents. Point mutations in ClC-5 alter kinetics, ion selectivity (S168T changes selectivity; E211A changes voltage dependence and ion selectivity), confirming these proteins are the channel-forming subunits.\",\n      \"method\": \"Heterologous expression in Xenopus oocytes and HEK293 cells; site-directed mutagenesis; two-electrode voltage clamp\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis combined with electrophysiology in two expression systems\",\n      \"pmids\": [\"9873029\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"ClC-5 operates with a 2 Cl⁻/1 H⁺ antiport stoichiometry. Nitrate uncouples proton transport. Mutation S168P converts ClC-5 into a coupled NO₃⁻/H⁺ exchanger, identifying serine 168 as a determinant of anion specificity. ClC-5 is allosterically stimulated by intracellular protons with apparent pK ~7.2.\",\n      \"method\": \"Novel extracellular proton imaging method in Xenopus oocytes; site-directed mutagenesis at position 168\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — quantitative flux measurement plus mutagenesis defining stoichiometry and mechanism\",\n      \"pmids\": [\"19131966\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"The cytoplasmic CBS domain of ClC-5 binds ATP and ADP at a specific nucleotide-binding site with high-micromolar affinity. Point mutations that interfere with nucleotide binding alter the transport behavior of ClC-5 expressed in Xenopus oocytes, demonstrating that CBS-domain nucleotide binding regulates transporter activity.\",\n      \"method\": \"X-ray crystallography of CBS domain with ATP/ADP; equilibrium dialysis; electrophysiology of CBS-domain mutants in Xenopus oocytes\",\n      \"journal\": \"Nature structural & molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure combined with binding assay and functional electrophysiology in same study\",\n      \"pmids\": [\"17195847\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"CLC-5 subcellular distribution in human kidney co-fractionates best with Rab4, a marker of recycling early endosomes, and co-localizes with albumin-containing endocytic vesicles of the receptor-mediated endocytic pathway in proximal tubular cells.\",\n      \"method\": \"Subcellular fractionation of human kidney; immunoblotting with Rab4 marker; confocal microscopy in opossum kidney cells\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct fractionation and confocal co-localization, foundational localization paper with 239 citations\",\n      \"pmids\": [\"9931332\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"CLC-5 knockout mice develop low molecular weight proteinuria, aminoaciduria, glycosuria, hypercalciuria, and severely impaired proximal tubular endocytosis of horseradish peroxidase, demonstrating that CLC-5 is required for endosomal uptake of low molecular weight proteins in vivo.\",\n      \"method\": \"Targeted gene disruption in mice (knockout); horseradish peroxidase endocytosis assay; urinary protein and amino acid analysis\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with specific endocytic and biochemical phenotypic readouts, 247 citations\",\n      \"pmids\": [\"11115837\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Loss of ClC-5 in knockout mice impairs endocytosis by causing a trafficking defect of the multiligand receptors megalin and cubilin in proximal tubule cells; megalin and cubilin are selectively lost from the brush border while total kidney content is reduced, despite preserved mRNA levels and normal Rab5a/Rab7 content.\",\n      \"method\": \"ClC-5 KO mouse; 125I-β2-microglobulin uptake assay; Percoll gradient fractionation; quantitative ultrastructural immunogold labeling; immunohistochemistry\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods in KO mice, 254 citations\",\n      \"pmids\": [\"12815097\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Endosomes from ClC-5 knockout mice acidify at a significantly lower rate than wild-type endosomes, consistent with ClC-5 providing an electrical shunt for the H⁺-ATPase. This endosomal acidification defect leads to impaired endocytosis. Additionally, defective PTH endocytosis raises luminal PTH, stimulating apical PTH receptors and causing phosphaturia and secondary up-regulation of proximal tubular α-hydroxylase.\",\n      \"method\": \"Endosomal acidification assay in KO vs. wild-type mice; PTH receptor stimulation studies; vitamin D metabolism measurements\",\n      \"journal\": \"Pflugers Archiv : European journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — functional acidification assay in KO model plus pathway epistasis, 159 citations\",\n      \"pmids\": [\"12548389\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The C-terminal tail of ClC-5 interacts with cofilin, an actin depolymerizing protein. Phosphorylation of cofilin by LIM kinase 1 stabilizes the actin cytoskeleton and strongly inhibits albumin uptake in proximal tubule cells, linking ClC-5's C-terminus to actin dynamics and receptor-mediated endocytosis.\",\n      \"method\": \"Yeast two-hybrid screen; GST-fusion pulldown; confocal co-localization; LIM kinase 1 overexpression with albumin endocytosis assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — yeast two-hybrid confirmed by pulldown and functional endocytosis assay in two cell lines\",\n      \"pmids\": [\"12904289\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"CLC-5 interacts with kinesin family member KIF3B (a microtubule motor) via the COOH-terminus of CLC-5 and the coiled-coil/globular domains of KIF3B. KIF3B overexpression increases CLC-5 surface expression and endocytosis; KIF3B siRNA knockdown has reciprocal effects. CLC-5-containing vesicles transport along KIF3B microtubules.\",\n      \"method\": \"Yeast two-hybrid; GST pulldown; co-immunoprecipitation (including endogenous); confocal live-cell imaging; siRNA knockdown; albumin/transferrin endocytosis assay\",\n      \"journal\": \"American journal of physiology. Renal physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including endogenous co-IP and live imaging with functional consequence\",\n      \"pmids\": [\"19940036\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Naturally occurring ClC-5 mutations that truncate the second CBS domain result in failure of ClC-5 to traffic to acidic endosomes; instead, the protein is retained in perinuclear compartments co-localizing with the Golgi complex, identifying CBS domain 2 as required for normal endosomal trafficking.\",\n      \"method\": \"Subcellular localization of CBS domain mutants by confocal microscopy with organelle markers in transfected cells\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single-lab localization study using naturally occurring mutations without functional rescue\",\n      \"pmids\": [\"14521953\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"ClC-5 mutations in Dent's disease patients cause altered polarity of H⁺-ATPase in proximal tubule cells (basolateral instead of apical distribution) and loss of apical H⁺-ATPase in α-type intercalated cells, without ultrastructural abnormalities in the endocytic apparatus.\",\n      \"method\": \"Immunohistochemistry of renal biopsies from eight Dent's disease patients with confirmed ClC-5 mutations\",\n      \"journal\": \"Kidney international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — direct immunohistochemical demonstration in patient biopsies with genotype confirmation\",\n      \"pmids\": [\"12631345\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"CLC-5 in rat intestinal cells co-fractionates with the vacuolar H⁺-ATPase and the early endosomal GTPases Rab4 and Rab5a, localizing it to early endosomes in enterocytes, and partially co-localizes with the transcytosed polymeric immunoglobulin receptor.\",\n      \"method\": \"Western blotting; indirect immunofluorescence; subcellular fractionation with vesicle markers\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — fractionation with multiple markers in intestinal tissue, moderate evidence for endosomal localization\",\n      \"pmids\": [\"11208533\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"ClC-5 knockout mice develop a euthyroid goiter with iodine accumulation and decreased pendrin (I⁻/Cl⁻ exchanger) expression (−60% at mRNA and protein levels). ClC-5 localizes to the apical pole of thyrocytes and best co-distributes with late endosomal marker Rab7. Loss of ClC-5 delays apical iodide efflux via pendrin downregulation rather than blocking apical endocytosis of thyroglobulin.\",\n      \"method\": \"ClC-5 KO mouse; thyroid 125I uptake assay; Percoll gradient fractionation; immunolocalization; RT-PCR and Western blot for pendrin\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse with multiple functional readouts and localization, single lab\",\n      \"pmids\": [\"16306076\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"PY-motif-dependent ubiquitylation of ClC-5 (via WWP2/Nedd4-2 interaction) is dispensable for its role in proximal tubular endocytosis in vivo. Knock-in mice with destroyed PY-motif show no proteinuria or endocytic defects, unlike ClC-5 knockout mice. ClC-5 is unique among CLC proteins in being essential for proximal tubular endocytosis.\",\n      \"method\": \"Genetic knock-in mice (PY-motif point mutation); comparison with KO and double-KO mice lacking ClC-3 or ClC-4; receptor-mediated and fluid-phase endocytosis assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — clean genetic epistasis with multiple mouse models and functional endocytosis assays\",\n      \"pmids\": [\"20351103\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"ClC-5 and megalin interact directly via their C-termini, and this interaction is scaffolded by NHERF2 in proximal tubule cells. NHERF2 silencing disrupts the ClC-5–megalin complex. A ternary complex of ClC-5, megalin, and NHERF2 was reconstituted with fusion proteins.\",\n      \"method\": \"GST pulldown; reciprocal co-immunoprecipitation from rat kidney lysate; siRNA against NHERF2; reconstitution of ternary complex with fusion proteins\",\n      \"journal\": \"The international journal of biochemistry & cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP from endogenous tissue combined with reconstitution and siRNA, single lab\",\n      \"pmids\": [\"22349218\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The gating glutamate Glu211 (external gate) is a major component of the gating charge underlying transient capacitive currents of ClC-5. Mutation E211D shifts transient currents ~150 mV to negative voltages. The gating mechanism involves intrinsic charge movement followed by voltage-dependent low-affinity binding of extracellular Cl⁻ ions.\",\n      \"method\": \"Two-electrode voltage clamp of transport-deficient E268A and E211D ClC-5 mutants in Xenopus oocytes; external and internal Cl⁻ and pH dependence analysis\",\n      \"journal\": \"Biophysical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro mutagenesis with quantitative biophysical analysis defining gating mechanism\",\n      \"pmids\": [\"22824269\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"The strong outward rectification of ClC-5 currents is partly caused by a gating mechanism (not solely transport mechanism), identified through mutation D76H which reveals inward tail currents with 2:1 Cl⁻:H⁺ stoichiometry at negative potentials, allowing reversal potential estimation for the first time.\",\n      \"method\": \"Site-directed mutagenesis (D76H); two-electrode voltage clamp in Xenopus oocytes; external/internal pH and Cl⁻ concentration dependence\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro mutagenesis with biophysical characterization defining gating vs. transport\",\n      \"pmids\": [\"24099800\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Several Dent's disease CLCN5 missense mutations fail to reach the plasma membrane and are retained in the ER/Golgi, indicating that correct channel structure is required for both function and Golgi exit. The R648X truncation mutant shows increased surface expression due to deletion of a C-terminal PY-like internalization signal.\",\n      \"method\": \"Heterologous expression in Xenopus oocytes and surface ELISA; two-electrode voltage-clamp analysis\",\n      \"journal\": \"Human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — surface expression and functional assay in two systems, single lab\",\n      \"pmids\": [\"15895257\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Dent's disease CLCN5 mutations fall into distinct mechanistic classes: Type I mutations allow normal trafficking to cell surface and early endosomes but reduce ion currents; Type II mutations cause retention in the ER due to impaired N-glycosylation and protein misfolding.\",\n      \"method\": \"Heterologous expression in Xenopus oocytes and HEK293 cells; N-glycosylation analysis; surface expression assays; confocal localization with endosomal markers\",\n      \"journal\": \"Kidney international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple mutations characterized by orthogonal methods in two expression systems\",\n      \"pmids\": [\"19657328\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"A pathogenic gating-glutamate mutation (E211G) converts ClC-5 from a Cl⁻/H⁺ antiporter into a Cl⁻ channel (abolishes outward rectification and H⁺ sensitivity) while maintaining normal plasma membrane and early endosome localization and normal endosomal acidification, demonstrating that impaired endosomal acidification is not the sole parameter leading to defective endocytosis in Dent disease.\",\n      \"method\": \"Site-directed mutagenesis; two-electrode voltage clamp in Xenopus oocytes; HEK293T expression; endosomal pH measurement with pHluorin2 probe\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis with electrophysiology plus orthogonal pH measurement, directly tests mechanistic model\",\n      \"pmids\": [\"29791050\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"ClC-5 exchanges 2 Cl⁻ out for 1 H⁺ in (2:1 stoichiometry confirmed by ion-selective microelectrodes). ClC-5 transport provides net negative charge acting as an 'on-off burst' shunting H⁺-ATPase during endosomal acidification. The S244L Dent mutation has slower transport and altered 1.6:1 stoichiometry; R345W traffics primarily to early endosomes in reduced quantity; Q629* is retained in ER/cis-Golgi.\",\n      \"method\": \"Ion-selective microelectrodes in Xenopus oocytes; organelle-specific fluorescent probes; chemiluminescent surface expression assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — quantitative stoichiometry measurements plus trafficking studies of multiple disease variants\",\n      \"pmids\": [\"31852738\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Disruption of clc-5 in collecting duct cells causes redistribution of annexin A2 from intracellular compartments to the plasma membrane, leading to increased cell-surface crystal retention and agglomeration of calcium phosphate and calcium oxalate crystals, which can be attenuated by anti-annexin A2 antibodies.\",\n      \"method\": \"Antisense clc-5 or truncated clc-5 overexpression in mIMCD-3 cells; immunofluorescence; crystal binding assay with antibody inhibition\",\n      \"journal\": \"Cellular and molecular life sciences : CMLS\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single lab, loss-of-function with specific mechanistic follow-up (antibody rescue)\",\n      \"pmids\": [\"16429322\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"In ClC-5 KO mice, kidney-specific upregulation of 1,25(OH)₂-vitamin D₃ target genes occurs despite reduced serum 1,25(OH)₂-vitamin D₃, because impaired proximal tubular endocytosis of the vitamin D precursor leads to increased 1,25(OH)₂-vitamin D₃ in distal nephron segments, contributing to pathogenesis of Dent's disease.\",\n      \"method\": \"Expression profiling, qRT-PCR, and hormone measurements in ClC-5 KO vs. wild-type mice; tissue-specific analysis (kidney, intestine, bone)\",\n      \"journal\": \"Kidney international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse with multiple quantitative measurements establishing kidney-specific pathway, single lab\",\n      \"pmids\": [\"16672909\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"CLCN5 is expressed in human podocytes, and its knockdown impairs transferrin endocytosis, decreases cell proliferation, and increases cell migration. A Dent disease mutation (L521F) shows differential subcellular localization compared with wild-type ClC-5 in podocytes, implicating ClC-5 in podocyte protein trafficking and slit diaphragm integrity.\",\n      \"method\": \"CLCN5 knockdown in cultured human podocytes; transferrin endocytosis assay; cell migration/proliferation assays; transfection of L521F mutant with fluorescence localization\",\n      \"journal\": \"Kidney international reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple functional readouts in human podocyte cells with disease mutation, single lab\",\n      \"pmids\": [\"30426109\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ClC-5 is an electrogenic 2Cl⁻/1H⁺ antiporter (not a passive Cl⁻ channel) resident in apical early endosomes of renal proximal tubule cells, where it provides Cl⁻ entry coupled to H⁺ export to facilitate H⁺-ATPase-driven endosomal acidification and Cl⁻ accumulation; its CBS domains bind nucleotides to regulate transport activity, its C-terminus interacts with cofilin, KIF3B, and megalin/NHERF2 scaffolds to coordinate vesicle trafficking and actin dynamics, and loss of ClC-5 function causes a trafficking defect of the endocytic receptors megalin and cubilin, severely impairing receptor-mediated endocytosis of low-molecular-weight proteins and producing the Dent disease phenotype.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"CLCN5 encodes ClC-5, an electrogenic 2Cl⁻/1H⁺ antiporter predominantly localized to early endosomes of renal proximal tubule cells, where it provides an electrical shunt for the vacuolar H⁺-ATPase to drive endosomal acidification and support receptor-mediated endocytosis [PMID:16034421, PMID:19131966, PMID:9931332, PMID:12548389]. ClC-5 transport activity is regulated by intracellular protons and by ATP/ADP binding to its cytoplasmic CBS domains; its C-terminus physically interacts with cofilin, KIF3B, and a megalin–NHERF2 scaffold complex, coupling vesicle trafficking, actin dynamics, and endocytic receptor positioning [PMID:17195847, PMID:12904289, PMID:19940036, PMID:22349218]. Loss of ClC-5 in knockout mice causes defective trafficking of the endocytic receptors megalin and cubilin, severely impairing proximal tubular uptake of low-molecular-weight proteins and producing proteinuria, aminoaciduria, hypercalciuria, and disordered vitamin D metabolism characteristic of Dent disease [PMID:11115837, PMID:12815097, PMID:16672909]. Dent disease–causing CLCN5 mutations act through distinct mechanisms: some abolish ion transport while preserving trafficking, and others cause ER retention due to protein misfolding, while conversion to a pure Cl⁻ channel (E211G) demonstrates that the coupled H⁺ transport mode itself is required for normal endocytosis beyond simple acidification [PMID:19657328, PMID:29791050].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"The first demonstration that ClC-5 encodes a functional ion-conducting protein established it as a kidney-expressed chloride transporter with strong outward rectification, opening the question of its physiological role.\",\n      \"evidence\": \"Heterologous expression of rat ClC-5 in Xenopus oocytes with two-electrode voltage clamp\",\n      \"pmids\": [\"8537381\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Transport vs. channel mechanism unresolved\", \"Subcellular localization unknown\", \"No link to disease pathophysiology yet\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Localization of ClC-5 to Rab4-positive early endosomes in proximal tubule cells and mutagenesis identifying key pore residues (S168, E211) redirected the field from plasma-membrane channel models toward an endosomal function.\",\n      \"evidence\": \"Subcellular fractionation of human kidney with immunoblotting; confocal co-localization; site-directed mutagenesis with electrophysiology in oocytes and HEK293 cells\",\n      \"pmids\": [\"9931332\", \"9873029\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of endosomal localization not yet demonstrated\", \"Whether endosomal acidification depends on ClC-5 untested\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"ClC-5 knockout mice recapitulated the Dent disease phenotype — low-molecular-weight proteinuria, aminoaciduria, and impaired proximal tubular endocytosis — establishing ClC-5 as essential for renal endocytic uptake in vivo.\",\n      \"evidence\": \"Targeted gene disruption in mice with HRP endocytosis assay and urinary biochemistry\",\n      \"pmids\": [\"11115837\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism linking ClC-5 loss to endocytic failure unknown\", \"Whether endosomal acidification is the primary defect unresolved\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Endosomes from ClC-5 KO mice acidified more slowly than wild-type, directly demonstrating that ClC-5 provides a counter-ion conductance that facilitates H⁺-ATPase-driven acidification, and linking defective acidification to impaired PTH clearance and downstream phosphaturia.\",\n      \"evidence\": \"Endosomal acidification assay in KO vs. WT mice; PTH receptor and vitamin D pathway measurements\",\n      \"pmids\": [\"12548389\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether ClC-5 functions as a channel or antiporter still unknown\", \"Relative contributions of acidification defect vs. other trafficking defects unclear\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Multiple studies converged to show that ClC-5 loss causes selective mistrafficking of megalin and cubilin from the brush border, that its C-terminus interacts with cofilin to regulate actin dynamics during endocytosis, and that disease mutations disrupting CBS domain 2 prevent endosomal targeting — revealing that ClC-5 has both ion-transport and protein-scaffolding roles.\",\n      \"evidence\": \"ClC-5 KO mice with immunogold labeling and Percoll fractionation; yeast two-hybrid and GST pulldown for cofilin; confocal localization of CBS-truncation mutants; patient renal biopsies\",\n      \"pmids\": [\"12815097\", \"12904289\", \"14521953\", \"12631345\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether cofilin interaction is direct in vivo or mediated by other factors\", \"Structural basis of CBS domain role in trafficking unknown\", \"Whether H⁺-ATPase mislocalization in patients is cause or consequence\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"The paradigm-shifting discovery that ClC-5 is a Cl⁻/H⁺ antiporter — not a passive Cl⁻ channel — fundamentally redefined its mechanism: it actively transports protons against their gradient, with the pore glutamate E211 serving as the proton-transfer residue.\",\n      \"evidence\": \"Extracellular pH measurements near cell surface in heterologous expression; E211A mutagenesis\",\n      \"pmids\": [\"16034421\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry not quantified\", \"How antiport (rather than channel) function serves endosomal physiology not yet clear\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"CBS-domain crystallography revealed a specific ATP/ADP binding site that directly regulates ClC-5 transport, while in vivo studies linked ClC-5 loss to both renal crystal retention via annexin A2 redistribution and disordered vitamin D metabolism, broadening the phenotypic consequences beyond proteinuria.\",\n      \"evidence\": \"X-ray crystallography of CBS domain with nucleotides plus oocyte electrophysiology; ClC-5 KO mice with crystal binding and vitamin D pathway measurements; antisense in mIMCD-3 cells\",\n      \"pmids\": [\"17195847\", \"16429322\", \"16672909\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How nucleotide binding allosterically alters transport cycle unknown\", \"Whether crystal retention contributes to nephrolithiasis in Dent patients unconfirmed\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Quantification of the 2Cl⁻:1H⁺ antiport stoichiometry, identification of intracellular proton activation (pK ~7.2), discovery of the KIF3B motor interaction, and classification of Dent mutations into trafficking-defective vs. transport-defective classes together built a comprehensive mechanistic framework.\",\n      \"evidence\": \"Extracellular proton imaging in oocytes; S168P mutagenesis; yeast two-hybrid and endogenous co-IP for KIF3B with live imaging; surface expression and glycosylation analysis of disease mutants\",\n      \"pmids\": [\"19131966\", \"19940036\", \"19657328\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether KIF3B interaction is essential for endosomal delivery in vivo untested\", \"Structural basis of the 2:1 stoichiometry not resolved\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"PY-motif-dependent ubiquitylation by Nedd4-2/WWP2 was shown to be dispensable for ClC-5's endocytic function in vivo, and ClC-5 was uniquely required among CLC family members for proximal tubular endocytosis, eliminating redundancy models.\",\n      \"evidence\": \"Genetic knock-in mice (PY-motif mutation) compared with KO and ClC-3/ClC-4 double-KO mice; receptor-mediated and fluid-phase endocytosis assays\",\n      \"pmids\": [\"20351103\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which internalization/recycling signals besides PY-motif regulate ClC-5 surface expression\", \"Why ClC-3 and ClC-4 cannot compensate despite shared localization\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identification of the ClC-5–megalin–NHERF2 ternary complex and elucidation of the E211 gating glutamate as the major charge-carrying residue in transient capacitive currents established that ClC-5 physically scaffolds the endocytic receptor and that its gating involves intrinsic charge movement prior to Cl⁻ binding.\",\n      \"evidence\": \"Reciprocal co-IP from rat kidney, NHERF2 siRNA, ternary complex reconstitution; voltage clamp of E211D and E268A mutants in oocytes\",\n      \"pmids\": [\"22349218\", \"22824269\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether NHERF2 disruption in vivo recapitulates Dent phenotype untested\", \"Full gating model lacking structural data on transmembrane conformational changes\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"The E211G mutation, which converts ClC-5 from antiporter to pure Cl⁻ channel while preserving normal trafficking and endosomal acidification, demonstrated that coupled H⁺ transport is required for endocytosis through a mechanism beyond simple pH regulation — a key conceptual advance separating the ion-coupling mode from acidification per se.\",\n      \"evidence\": \"Mutagenesis with electrophysiology in oocytes; endosomal pH measurement with pHluorin2 in HEK293T cells\",\n      \"pmids\": [\"29791050\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"What downstream process requires the antiport mode specifically (e.g. Cl⁻ accumulation, endosomal voltage) remains unidentified\", \"Whether this applies in proximal tubule cells in vivo not tested\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Ion-selective microelectrode measurements confirmed the 2:1 Cl⁻:H⁺ stoichiometry and revealed that ClC-5 operates in burst mode, while disease mutant S244L showed altered stoichiometry (1.6:1), directly linking stoichiometric fidelity to disease pathogenesis.\",\n      \"evidence\": \"Ion-selective microelectrodes in Xenopus oocytes; organelle fluorescent probes; multiple Dent mutant characterization\",\n      \"pmids\": [\"31852738\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How altered stoichiometry causes endocytic failure mechanistically unclear\", \"No high-resolution structure of full-length mammalian ClC-5 available\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The key unresolved question is why the antiport coupling mode — rather than simple Cl⁻ conductance — is essential for endocytosis, and whether this reflects a requirement for endosomal Cl⁻ accumulation, specific membrane voltage, or signaling to the megalin–cubilin trafficking machinery.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No high-resolution structure of full-length ClC-5 in a lipid membrane\", \"The specific downstream effector of antiport-mode coupling in endocytosis is unidentified\", \"Whether ClC-5's scaffolding interactions (cofilin, KIF3B, NHERF2-megalin) are independently essential or cooperative in vivo is untested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 1, 3, 17, 18, 22]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [5, 7, 11, 13]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [1, 2, 19, 22]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [5, 6, 7, 8, 10, 15]},\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [0, 3, 22]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [6, 7, 12, 20, 21]}\n    ],\n    \"complexes\": [\n      \"ClC-5–megalin–NHERF2 ternary complex\"\n    ],\n    \"partners\": [\n      \"LRP2\",\n      \"NHERF2\",\n      \"KIF3B\",\n      \"CFL1\",\n      \"ANXA2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}